Clinical Director and Head of Small Animal Internal Medicine
Anicura Ospedale Veterinario i Portoni Rossi
DMV, MVetMed, DACVIM, Dipl ECVIM-CA, MRCVS
Dr. Procoli graduated from the University of Bari, Italy in 2003. He worked in small animal general practice in Italy and UK for 5 years. In 2009 he completed a rotating internship at the Royal (Dick) School of Veterinary Sciences in Edinburgh (Scotland). In 2012 he completed a 3-year a residency program in small animal internal medicine at the Royal Veterinary College in London, (England). In 2013 and 2014 he was awarded the title of board-certified specialist in small animal internal medicine both by the American (ACVIM) and the European College of Veterinary Internal Medicine (ECVIM). In 2014 he completed a 1-year research master degree at the Royal Veterinary College in London on the genetics of chronic enteropathy in Germans shepherd dogs. From 2014 to 2017 he has been Deputy Head of Internal Medicine at Anderson Moores Veterinary Specialists in Winchester (UK). From 2017 he is Head of Internal Medicine and from 2024 Clinical Director at Anicura Ospedale Veterinario i Portoni Rossi in Bologna (Italy) . Dr. Procoli has authored and co-authored publications in national and international peer-reviewed journals on the topics of small animal gastroenterology. He is author of the Feline Gastroenterology textbook published by Edra (2021 Ed). He has widely spoken and lectured at national and international continuing education events and courses on all topics of small animal gastroenterology and internal medicine. He is President of the Italian Society of Veterinary Internal Medicine (SIMIV) and of the European Society of Comparative Gastroenterology (ESCG).
Date
Chronic diarrhoea and gastrointestinal signs in dogs are very common. Clinical presentation and diagnostic test results often overlap across different underlying diseases. In this presentation, Dr Procoli will present an evidence based yet practical algorithm to approach chronic diarrhoea in dogs from diagnosis to treatment. With the help of real case scenarios will review the central role of dietary trials and microbiota modulating therapies in the management of this common clinical presentation.